Long non-coding RNA HAND2-AS1 targets glucose metabolism and inhibits cancer cell proliferation in osteosarcoma

Shunguang Chen1, Xiaoming Xu1, Shengjun Lu1

  • 1Department of Orthopedics, Jingzhou Central Hospital, Jingzhou, Hubei 434020, P.R. China.

Oncology Letters
|August 20, 2019
PubMed

Insights

Long non-coding RNA HAND2-AS1 (lncRNA HAND2-AS1) acts as a tumor suppressor in osteosarcoma. Reduced HAND2-AS1 levels promote cancer cell proliferation by increasing glucose metabolism, suggesting its therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Long non-coding RNA heart and neural crest derivatives expressed 2-antisense RNA 1 (lncRNA HAND2-AS1) is a known tumor suppressor in endometrial carcinoma.
  • The role of lncRNA HAND2-AS1 in osteosarcoma remains unexplored.

Purpose of the Study:

  • To investigate the expression and function of lncRNA HAND2-AS1 in osteosarcoma.
  • To determine the relationship between lncRNA HAND2-AS1 and osteosarcoma progression.

Main Methods:

  • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) to detect HAND2-AS1 expression in tumor tissues and serum.
  • Transfection of osteosarcoma cells with HAND2-AS1 small interfering RNA (siRNA).
  • Cell Counting Kit-8, western blotting, and glucose uptake assays to assess cell proliferation, glucose transporter 1 (GLUT1) expression, and glucose uptake.

Main Results:

  • HAND2-AS1 expression was significantly reduced in osteosarcoma tissues and serum compared to healthy controls.
  • Lower serum HAND2-AS1 levels correlated with larger tumor size.
  • HAND2-AS1 knockdown promoted osteosarcoma cell proliferation, increased glucose uptake, and upregulated GLUT1 expression.

Conclusions:

  • lncRNA HAND2-AS1 functions as a tumor suppressor in osteosarcoma.
  • HAND2-AS1 may inhibit osteosarcoma cell proliferation by regulating glucose metabolism via GLUT1.
  • Serum HAND2-AS1 levels could serve as a potential biomarker for osteosarcoma tumor size.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
5.0K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.4K
What is Metabolism?00:52

What is Metabolism?

Overview
131.2K